A detailed history of Virtu Financial LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 19,165 shares of ANNX stock, worth $99,083. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,165
Previous 29,664 35.39%
Holding current value
$99,083
Previous $145,000 22.07%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

SELL
$4.49 - $7.2 $47,140 - $75,592
-10,499 Reduced 35.39%
19,165 $113,000
Q2 2024

Aug 09, 2024

SELL
$4.33 - $6.79 $69,565 - $109,088
-16,066 Reduced 35.13%
29,664 $145,000
Q1 2024

May 20, 2024

SELL
$4.03 - $7.81 $11,622 - $22,524
-2,884 Reduced 5.93%
45,730 $328,000
Q4 2023

Feb 26, 2024

BUY
$1.63 - $4.63 $79,240 - $225,082
48,614 New
48,614 $221,000
Q1 2023

May 01, 2023

BUY
$3.74 - $7.46 $75,304 - $150,207
20,135 New
20,135 $78,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $246M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.